H. pylori eradication therapy.
McLaughlin
R P
RP
MediSphere, Birmingham, Alabama, USA.
D000900:Anti-Bacterial Agents; D003365:Costs and Cost Analysis; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000191:economics; D016481:Helicobacter Infections / Q000188:drug therapy / Q000191:economics; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000191:economics
D000900:Anti-Bacterial Agents